A Phase I/II Study of the mTOR Inhibitor Everolimus in Combination with HyperCVAD Chemotherapy in Patients with Relapsed/Refractory Acute Lymphoblastic Leukemia
暂无分享,去创建一个
K. Baggerly | M. Konopleva | Wenbin Liu | H. Kantarjian | Y. Boumber | J. Cortes | F. Ravandi | E. Jabbour | N. Daver | Z. Zeng | S. O'brien | J. Burger | Lianchun Xiao | J. Kawedia | L. Bendall | M. Richie | M. Rytting | K. Culotta | J. Basnett | Deborah M. Thomas | Hongbo Lu | Rebecca E. Garris